EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Early serum TIMP-2 as a biomarker for 90-day chronic kidney disease after percutaneous coronary intervention in ST-elevation myocardial infarction: a prospective cohort study

Miras Mugazov, Eldar Saparov, Dmitriy Vassilyev, Alina Ogizbayeva, Natalya Vassilyeva, Dinara Omertayeva

BMC Cardiovascular Disorders · 06.05.2026 · 26 (1)

DOI: 10.1186/s12872-026-05904-8 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift BMC Cardiovascular Disorders, online erschienen am 06.05.2026. Verfasst von Miras Mugazov und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medical Care, Anesthesiology and Resuscitation, NJSC Karaganda Medical University, Karaganda, Kazakhstan. Hauptthemen laut MEDLINE: Tissue Inhibitor of Metalloproteinase-2, Percutaneous Coronary Intervention, ST Elevation Myocardial Infarction, Renal Insufficiency, Chronic. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Contrast-induced acute kidney injury (CI-AKI) remains a concern in patients with ST-elevation myocardial infarction (STEMI) undergoing emergent percutaneous coronary intervention (PCI), but creatinine-based CI-AKI definitions incompletely capture longer-term renal trajectories. Early tubular stress biomarkers such as tissue inhibitor of metalloproteinases-2 (TIMP-2) may provide incremental risk information beyond conventional functional markers.

Methods

In this prospective single-centre cohort, we enrolled 88 consecutive STEMI patients undergoing urgent coronary angiography with or without PCI. Routine laboratory parameters were obtained at admission and 48 h. Serum TIMP-2 was measured 2 h after the procedure using a standardized sandwich ELISA. Early CI-AKI was defined by conventional creatinine-based criteria within 48 h, whereas 90-day chronic kidney disease (CKD) was defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m² or persistent creatinine elevation at 90 days. We evaluated paired changes, between-group differences by 90-day CKD status, correlations, multivariable linear and logistic regression, and receiver operating characteristic (ROC) discrimination.

Results

Early CI-AKI occurred in 6/88 patients (6.8%), whereas 90-day CKD was diagnosed in 15/88 (17%), indicating substantial delayed renal dysfunction beyond the 48-h window. The median 2-h serum TIMP-2 concentration was 1.20 ± 0.38 ng/mL. TIMP-2 showed modest correlations with creatinine and urea and remained independently associated with higher 90-day creatinine in multivariable linear regression (B = + 12.0 µmol/L per 1-ng/mL increase; p = 0.016) after adjustment for baseline creatinine and clinical covariates. In parsimonious logistic models, TIMP-2 demonstrated a borderline association with 90-day CKD (odds ratio ≈ 6.38; p = 0.056), while older age was a significant predictor. Standalone ROC discrimination for 90-day CKD was limited (AUC 0.528; 95% confidence interval 0.39–0.65; p = 0.668).

Conclusions

In STEMI patients undergoing emergent angiography/PCI, 90-day CKD was considerably more frequent than early creatinine-defined CI-AKI, underscoring the need for extended renal follow-up. A single 2-hour serum TIMP-2 measurement reflects early tubular stress and independently associates with 90-day creatinine, but offers only modest standalone discrimination for 90-day CKD. TIMP-2 is therefore more likely to have a role within multivariable or biomarker panel-based risk stratification pathways rather than as an isolated classifier.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue Inhibitor of Metalloproteinase-2Percutaneous Coronary InterventionST Elevation Myocardial InfarctionRenal Insufficiency, ChronicAcute Kidney InjuryContrast MediaHumansProspective StudiesFemaleBiomarkersMaleAgedMiddle AgedTime FactorsGlomerular Filtration RateCreatinineRisk FactorsCoronary AngiographyROC CurveLogistic ModelsPredictive Value of TestsMultivariate AnalysisTreatment OutcomeEnzyme-Linked Immunosorbent Assay

Stichwörter der Autor:innen

Cardio–renal syndromeChronic kidney diseaseContrast-induced acute kidney injuryPercutaneous coronary interventionST-elevation myocardial infarctionTIMP-2Tubular stress biomarkers

Substanzen

Tissue Inhibitor of Metalloproteinase-2BiomarkersTIMP2 protein, humanCreatinineContrast Media

Autor:innen und Institutionen

  • Department of Emergency Medical Care, Anesthesiology and Resuscitation, NJSC Karaganda Medical University, Karaganda, Kazakhstan.
  • Department of Obstetrics, Gynecology and Perinatology, NJSC Karaganda Medical University, Karaganda, Kazakhstan. omertaeva@qmu.kz.

Zitieren

APA

Mugazov, M., Saparov, E., Vassilyev, D., Ogizbayeva, A., Vassilyeva, N., & Omertayeva, D. (2026). Early serum TIMP-2 as a biomarker for 90-day chronic kidney disease after percutaneous coronary intervention in ST-elevation myocardial infarction: a prospective cohort study. BMC Cardiovascular Disorders, 26(1). https://doi.org/10.1186/s12872-026-05904-8

Vancouver

Mugazov M, Saparov E, Vassilyev D, Ogizbayeva A, Vassilyeva N, Omertayeva D. Early serum TIMP-2 as a biomarker for 90-day chronic kidney disease after percutaneous coronary intervention in ST-elevation myocardial infarction: a prospective cohort study. BMC Cardiovascular Disorders. 2026;26(1). doi:10.1186/s12872-026-05904-8

BibTeX
@article{Mugazov2026,
  author = {Mugazov, Miras and Saparov, Eldar and Vassilyev, Dmitriy and Ogizbayeva, Alina and Vassilyeva, Natalya and Omertayeva, Dinara},
  title = {Early serum TIMP-2 as a biomarker for 90-day chronic kidney disease after percutaneous coronary intervention in ST-elevation myocardial infarction: a prospective cohort study},
  journal = {BMC Cardiovascular Disorders},
  year = {2026},
  volume = {26},
  number = {1},
  doi = {10.1186/s12872-026-05904-8}
}
Kostenlos starten →